InChI=1S/C34H43F5O5S/c1-32-21-28(31-26-13-9-24(40)20-23(26)8-12-27(31)29(32)14-15-30(32)41)22-6-10-25(11-7-22)44-17-3-2-4-18-45(42,43)19-5-16-33(35,36)34(37,38)39/h6-7,9-11,13,20,27-31,40-41H,2-5,8,12,14-19,21H2,1H3/t27-,28+,29-,30-,31+,32-/m0/s1 |
SDCUWFRXMLQNCS-LFAPAAFUSA-N |
[C@]12(CCC3=C([C@]1([C@H](C[C@@]4(C)[C@@]2([H])CC[C@@H]4O)C5=CC=C(C=C5)OCCCCCS(CCCC(C(F)(F)F)(F)F)(=O)=O)[H])C=CC(=C3)O)[H] |
|
estrogen receptor antagonist
An antagonist at the estrogen receptor.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
anti-estrogen
A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.
estrogen receptor antagonist
An antagonist at the estrogen receptor.
|
|
View more via ChEBI Ontology
11β-[4-({5-[(4,4,5,5,5-pentafluoropentyl)sulfonyl]pentyl}oxy)phenyl]estra-1,3,5(10)-triene-3,17β-diol
|
(11β,17β)-11-[4-({5-[(4,4,5,5,5-pentafluoropentyl)sulfonyl]pentyl}oxy)phenyl]estra-1,3,5(10)-triene-3,17-diol
|
IUPAC
|
11β-[4-({5-[(4,4,5,5,5-pentafluoropentyl)sulfonyl]pentyl}oxy)phenyl]-17β-estradiol
|
ChEBI
|
RU 58 668
|
ChemIDplus
|
RU 58,668
|
ChEBI
|
RU-58668
|
ChEBI
|
RU58668
|
ChemIDplus
|
151555-47-4
|
CAS Registry Number
|
ChemIDplus
|
7454158
|
Reaxys Registry Number
|
Reaxys
|
12880293
|
PubMed citation
|
Europe PMC
|
14757510
|
PubMed citation
|
Europe PMC
|
16753295
|
PubMed citation
|
Europe PMC
|
7625719
|
PubMed citation
|
Europe PMC
|
8142294
|
PubMed citation
|
Europe PMC
|
8879676
|
PubMed citation
|
Europe PMC
|
9010350
|
PubMed citation
|
Europe PMC
|
9355049
|
PubMed citation
|
Europe PMC
|
|